We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Alternative to CPR

By HospiMedica staff writers
Posted on 11 Aug 2005
A compact, portable cardiopulmonary resuscitation (CPR) device that automatically performs cardiac resuscitation allows rescuers to focus on ventilation and other interventions.

To deploy the device, called AutoPulse, the rescuer aligns the patient on the AutoPulse platform, closes the LifeBand chest band over the patient's chest, and presses "Start”. AutoPulse takes over the task of performing chest compressions in order to circulate blood to the heart and brain. The device can be rapidly deployed, adjusts the force of compressions automatically to each patient's weight and chest circumference, and applies a consistent depth and range of compressions.

There is general agreement that a system better than CPR is needed. Most CPR patients are elderly and the procedure works less than 10% of the time for them, according to Robert Shmerling, a professor of medicine at Harvard Medical School (Boston, MA, USA). This can be due to the fact that a rescuer's hands may miss the correct location on a patient's chest. AutoPulse straps the patient into the device, enveloping the entire chest so that compressions hit the right location.

The AutoPulse is marketed by Zoll Medical Corp. (Chelmsford, MA, USA). The device was developed by Revivant Corp., which was acquired in 2004 by Zoll. According to Zoll, the device is often used along with manual CPR. The American Heart Association (AHA, Dallas, TX, USA) has categorized the device as a "reasonable” alternative to manual CPR, but has not recommended either system.

According to studies cited by Zoll, the AutoPulse has been shown to restore levels of blood flow to the heart and brain much better than CPR and to improve survival. At the price of U.S. $15,000 for the device, many emergency medical teams may feel they cannot afford it.




Related Links:
Zoll Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Resting Electrocardiograph
ECG Top D/BT
New
Single-Use Instrumentation
FASTPAK

Latest Critical Care News

Breakthrough Technique Stops Irregular Heartbeats

AI Model Accurately Predicts Progression of Autoimmune Disease

AI Predicts and Identifies Subtypes of Type 2 Diabetes from Continuous Blood Glucose Monitor